Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pepify is a brand of digestive enzyme and gastrointestinal health formulations developed and manufactured by Anglo-French Drugs & Industries. It is available in two main formulations: Pepify Syrup, which contains fungal diastase and pepsin, and Pepify Tablets, which contain pancreatin, activated charcoal, ox bile extract, and ginger oleoresin. Pepify is indicated for the relief of indigestion, dyspepsia, flatulence, bloating, heartburn, abdominal pain, and nausea. The active ingredients work synergistically to promote the breakdown of carbohydrates, proteins, and lipids, facilitate gastric emptying, adsorb intestinal gases, and support overall digestive function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Pepify.